CHEN JIN-LONG
Insider CIK 1642996 · NGM Chief Scientific Officer, Director · TNYA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 175,000 | — | $0 | 175,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 192,000 | — | $0 | 192,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award | 2023-03-02 | 2023-03-06 | 64,000 | — | $0 | 972,893 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2023-01-17 | 2023-01-18 | 85,082 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2023-01-17 | 2023-01-18 | 85,082 | $5.15 | $438.2K | 908,893 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2023-01-17 | 2023-01-18 | 85,082 | $1.44 | $122.5K | 993,975 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2022-03-03 | 2022-03-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-12-07 | 2021-12-07 | 15,000 | $18.60 | $279.0K | 908,893 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-12-06 | 2021-12-07 | 69,444 | — | $0 | 85,082 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-12-06 | 2021-12-07 | 69,444 | $1.44 | $100.0K | 923,893 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-12-06 | 2021-12-07 | 15,000 | $18.21 | $273.1K | 854,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-11-15 | 2021-11-16 | 15,000 | $19.56 | $293.4K | 869,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-11-15 | 2021-11-16 | 15,000 | $19.89 | $298.4K | 884,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-10-12 | 2021-10-13 | 15,000 | $20.14 | $302.1K | 899,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-10-11 | 2021-10-13 | 15,000 | $20.41 | $306.1K | 914,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-09-14 | 2021-09-14 | 11,963 | $25.54 | $305.5K | 932,486 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-09-14 | 2021-09-14 | 3,037 | $26.13 | $79.4K | 929,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-09-13 | 2021-09-14 | 170 | $26.98 | $4.6K | 944,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-09-13 | 2021-09-14 | 3,920 | $25.59 | $100.3K | 955,529 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-09-13 | 2021-09-14 | 10,910 | $26.17 | $285.5K | 944,619 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-08-10 | 2021-08-11 | 15,000 | $23.15 | $347.3K | 959,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-08-09 | 2021-08-11 | 600 | $25.62 | $15.4K | 974,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-08-09 | 2021-08-11 | 7,731 | $23.81 | $184.1K | 981,718 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-08-09 | 2021-08-11 | 6,669 | $25.12 | $167.5K | 975,049 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-06-03 | 2021-06-07 | 69,444 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-06-03 | 2021-06-07 | 69,444 | $1.44 | $100.0K | 989,449 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-05-03 | 2021-05-04 | 25,000 | $27.62 | $690.5K | 920,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-04-12 | 2021-04-13 | 25,000 | $24.65 | $616.3K | 945,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2021-03-17 | 2021-03-18 | 175,000 | — | $0 | 175,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-03-01 | 2021-03-02 | 25,000 | $26.66 | $666.5K | 970,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-02-16 | 2021-02-17 | 25,000 | $28.75 | $718.8K | 995,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-01-05 | 2021-01-06 | 150,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-01-05 | 2021-01-06 | 150,000 | $0.60 | $90.0K | 1,020,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-01-04 | 2021-01-06 | 370 | $30.26 | $11.2K | 870,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-01-04 | 2021-01-06 | 24,630 | $29.27 | $720.9K | 870,375 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-12-14 | 2020-12-16 | 3,145 | $28.89 | $90.9K | 895,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-12-14 | 2020-12-16 | 10,729 | $28.19 | $302.5K | 898,150 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-12-14 | 2020-12-16 | 11,126 | $27.59 | $307.0K | 908,879 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-11-02 | 2020-11-04 | 25,000 | $17.70 | $442.5K | 920,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-10-12 | 2020-10-13 | 25,000 | $17.02 | $425.5K | 945,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-09-01 | 2020-09-03 | 17,387 | $17.62 | $306.4K | 977,618 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-09-01 | 2020-09-03 | 7,613 | $18.32 | $139.5K | 970,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-08-10 | 2020-08-11 | 25,000 | $19.02 | $475.5K | 995,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-07-01 | 2020-07-02 | 17,737 | $18.79 | $333.3K | 1,027,268 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-07-01 | 2020-07-02 | 7,263 | $19.20 | $139.4K | 1,020,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-06-15 | 2020-06-17 | 5,600 | $21.15 | $118.4K | 1,064,405 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-06-15 | 2020-06-17 | 19,400 | $21.79 | $422.7K | 1,045,005 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2020-02-04 | 2020-02-06 | 175,000 | — | $0 | 175,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2020-01-09 | 2020-01-09 | 18,641 | $1.44 | $26.8K | 154,526 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2020-01-09 | 2020-01-09 | 18,641 | $1.44 | $26.8K | 1,087,084 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-01-09 | 2020-01-09 | 18,641 | $17.95 | $334.6K | 1,068,443 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2020-01-08 | 2020-01-09 | 71,750 | $0.52 | $37.3K | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2020-01-08 | 2020-01-09 | 1,833 | $1.44 | $2.6K | 173,167 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2020-01-08 | 2020-01-09 | 14,201 | $1.44 | $20.4K | 69,444 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2020-01-08 | 2020-01-09 | 1,833 | $1.44 | $2.6K | 998,526 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-01-08 | 2020-01-09 | 14,201 | $17.98 | $255.3K | 996,693 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2020-01-08 | 2020-01-09 | 14,201 | $1.44 | $20.4K | 1,010,894 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-01-08 | 2020-01-09 | 1,833 | $17.98 | $33.0K | 996,693 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2020-01-08 | 2020-01-09 | 71,750 | $0.52 | $37.3K | 1,068,443 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2020-01-07 | 2020-01-09 | 16,090 | $1.44 | $23.2K | 83,645 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-01-07 | 2020-01-09 | 16,090 | $18.20 | $292.8K | 996,693 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2020-01-07 | 2020-01-09 | 16,090 | $1.44 | $23.2K | 1,012,783 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2019-11-04 | 2019-11-04 | 10,986 | $1.44 | $15.8K | 99,735 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2019-11-04 | 2019-11-04 | 10,986 | $12.26 | $134.7K | 996,693 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2019-11-04 | 2019-11-04 | 10,986 | $1.44 | $15.8K | 1,007,679 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2019-11-01 | 2019-11-04 | 71,750 | $0.52 | $37.3K | 71,750 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2019-11-01 | 2019-11-04 | 11,403 | $1.44 | $16.4K | 110,721 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2019-11-01 | 2019-11-04 | 71,750 | $0.52 | $37.3K | 996,693 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2019-11-01 | 2019-11-04 | 11,403 | $13.29 | $151.5K | 924,943 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2019-11-01 | 2019-11-04 | 11,403 | $1.44 | $16.4K | 936,346 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2019-10-31 | 2019-11-04 | 28,376 | $1.44 | $40.9K | 122,124 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2019-10-31 | 2019-11-04 | 28,376 | $12.99 | $368.6K | 924,943 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2019-10-31 | 2019-11-04 | 28,376 | $1.44 | $40.9K | 953,319 | SEC↗ |